292 related articles for article (PubMed ID: 8218285)
1. Three distinct domains in the cholinesterase molecule confer selectivity for acetyl- and butyrylcholinesterase inhibitors.
Radić Z; Pickering NA; Vellom DC; Camp S; Taylor P
Biochemistry; 1993 Nov; 32(45):12074-84. PubMed ID: 8218285
[TBL] [Abstract][Full Text] [Related]
2. Amino acid residues controlling acetylcholinesterase and butyrylcholinesterase specificity.
Vellom DC; Radić Z; Li Y; Pickering NA; Camp S; Taylor P
Biochemistry; 1993 Jan; 32(1):12-7. PubMed ID: 8418833
[TBL] [Abstract][Full Text] [Related]
3. Differences in active site gorge dimensions of cholinesterases revealed by binding of inhibitors to human butyrylcholinesterase.
Saxena A; Redman AM; Jiang X; Lockridge O; Doctor BP
Biochemistry; 1997 Dec; 36(48):14642-51. PubMed ID: 9398183
[TBL] [Abstract][Full Text] [Related]
4. Differences in active-site gorge dimensions of cholinesterases revealed by binding of inhibitors to human butyrylcholinesterase.
Saxena A; Redman AM; Jiang X; Lockridge O; Doctor BP
Chem Biol Interact; 1999 May; 119-120():61-9. PubMed ID: 10421439
[TBL] [Abstract][Full Text] [Related]
5. Specificity and orientation of trigonal carboxyl esters and tetrahedral alkylphosphonyl esters in cholinesterases.
Hosea NA; Berman HA; Taylor P
Biochemistry; 1995 Sep; 34(36):11528-36. PubMed ID: 7547883
[TBL] [Abstract][Full Text] [Related]
6. Does "butyrylization" of acetylcholinesterase through substitution of the six divergent aromatic amino acids in the active center gorge generate an enzyme mimic of butyrylcholinesterase?
Kaplan D; Ordentlich A; Barak D; Ariel N; Kronman C; Velan B; Shafferman A
Biochemistry; 2001 Jun; 40(25):7433-45. PubMed ID: 11412096
[TBL] [Abstract][Full Text] [Related]
7. Aromatic amino-acid residues at the active and peripheral anionic sites control the binding of E2020 (Aricept) to cholinesterases.
Saxena A; Fedorko JM; Vinayaka CR; Medhekar R; Radić Z; Taylor P; Lockridge O; Doctor BP
Eur J Biochem; 2003 Nov; 270(22):4447-58. PubMed ID: 14622273
[TBL] [Abstract][Full Text] [Related]
8. Identification of amino acid residues involved in the binding of Huperzine A to cholinesterases.
Saxena A; Qian N; Kovach IM; Kozikowski AP; Pang YP; Vellom DC; Radić Z; Quinn D; Taylor P; Doctor BP
Protein Sci; 1994 Oct; 3(10):1770-8. PubMed ID: 7849595
[TBL] [Abstract][Full Text] [Related]
9. Chimeric human cholinesterase. Identification of interaction sites responsible for recognition of acetyl- or butyrylcholinesterase-specific ligands.
Loewenstein Y; Gnatt A; Neville LF; Soreq H
J Mol Biol; 1993 Nov; 234(2):289-96. PubMed ID: 8230213
[TBL] [Abstract][Full Text] [Related]
10. Amino acid residues involved in stereoselective inhibition of cholinesterases with bambuterol.
Bosak A; Gazić I; Vinković V; Kovarik Z
Arch Biochem Biophys; 2008 Mar; 471(1):72-6. PubMed ID: 18167304
[TBL] [Abstract][Full Text] [Related]
11. New data on the structure of the acyl pocket in cholinesterases.
Moralev SN
Dokl Biochem; 2000; 375():215-7. PubMed ID: 11296473
[No Abstract] [Full Text] [Related]
12. Site of fasciculin interaction with acetylcholinesterase.
Radić Z; Duran R; Vellom DC; Li Y; Cervenansky C; Taylor P
J Biol Chem; 1994 Apr; 269(15):11233-9. PubMed ID: 8157652
[TBL] [Abstract][Full Text] [Related]
13. Amino acid residues involved in the interaction of acetylcholinesterase and butyrylcholinesterase with the carbamates Ro 02-0683 and bambuterol, and with terbutaline.
Kovarik Z; Radić Z; Grgas B; Skrinjarić-Spoljar M; Reiner E; Simeon-Rudolf V
Biochim Biophys Acta; 1999 Aug; 1433(1-2):261-71. PubMed ID: 10446376
[TBL] [Abstract][Full Text] [Related]
14. Conversion of acetylcholinesterase to butyrylcholinesterase: modeling and mutagenesis.
Harel M; Sussman JL; Krejci E; Bon S; Chanal P; Massoulié J; Silman I
Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10827-31. PubMed ID: 1438284
[TBL] [Abstract][Full Text] [Related]
15. Probing the mid-gorge of cholinesterases with spacer-modified bivalent quinazolinimines leads to highly potent and selective butyrylcholinesterase inhibitors.
Chen X; Tikhonova IG; Decker M
Bioorg Med Chem; 2011 Feb; 19(3):1222-35. PubMed ID: 21232964
[TBL] [Abstract][Full Text] [Related]
16. Acetylcholinesterase active centre and gorge conformations analysed by combinatorial mutations and enantiomeric phosphonates.
Kovarik Z; Radić Z; Berman HA; Simeon-Rudolf V; Reiner E; Taylor P
Biochem J; 2003 Jul; 373(Pt 1):33-40. PubMed ID: 12665427
[TBL] [Abstract][Full Text] [Related]
17. The mechanism and benefit of human butyrylcholinesterase activation by what would otherwise be inhibitors.
Stojan J
Chem Biol Interact; 2019 Aug; 308():350-356. PubMed ID: 31173753
[TBL] [Abstract][Full Text] [Related]
18. Role of tyrosine 337 in the binding of huperzine A to the active site of human acetylcholinesterase.
Ashani Y; Grunwald J; Kronman C; Velan B; Shafferman A
Mol Pharmacol; 1994 Mar; 45(3):555-60. PubMed ID: 8145739
[TBL] [Abstract][Full Text] [Related]
19. Reversible inhibition of acetylcholinesterase and butyrylcholinesterase by 4,4'-bipyridine and by a coumarin derivative.
Simeon-Rudolf V; Kovarik Z; Radić Z; Reiner E
Chem Biol Interact; 1999 May; 119-120():119-28. PubMed ID: 10421445
[TBL] [Abstract][Full Text] [Related]
20. Dissection of the human acetylcholinesterase active center determinants of substrate specificity. Identification of residues constituting the anionic site, the hydrophobic site, and the acyl pocket.
Ordentlich A; Barak D; Kronman C; Flashner Y; Leitner M; Segall Y; Ariel N; Cohen S; Velan B; Shafferman A
J Biol Chem; 1993 Aug; 268(23):17083-95. PubMed ID: 8349597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]